Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation

Sofia Nascimento dos Santos(Instituto de Pesquisas Energéticas e Nucleares), Emerson Soares Bernardes(Instituto de Pesquisas Energéticas e Nucleares), Esther Bridges(University of Oxford), Helen Sheldon(Cancer Research UK), Adrian L. Harris(John Radcliffe Hospital), Christopher Paluch(University of Oxford), Márcia Curry El-Cheikh(Universidade Federal do Rio de Janeiro), Jonathas Xavier Pereira(Universidade Federal do Rio de Janeiro)
Oncotarget
May 9, 2017
Cited by 82


Related Papers